APOL1-MEDIATED KIDNEY DISEASE

Clinical trials for APOL1-MEDIATED KIDNEY DISEASE explained in plain language.

Never miss a new study

Get alerted when new APOL1-MEDIATED KIDNEY DISEASE trials appear

Sign up with your email to follow new studies for APOL1-MEDIATED KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Experimental drug targets genetic cause of kidney damage

Disease control Recruiting now

This study is testing whether a new drug called AZD2373 can help people with APOL1-mediated kidney disease, a genetic condition that damages the kidneys. About 96 participants with specific genetic markers will receive either the drug or a placebo for at least 30 weeks. Researche…

Matched conditions: APOL1-MEDIATED KIDNEY DISEASE

Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

APOL1-MEDIATED KIDNEY DISEASE

Get alerted when new APOL1-MEDIATED KIDNEY DISEASE trials appear

Experimental drug targets genetic cause of kidney damage